N-[4-[[(3R)-3-methoxypyrrolidin-1-yl]methyl]-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(5-methyl-1H-pyrazol-4-yl)-N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-(1H-pyrazol-4-yl)-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(1H-pyrazol-4-yl)-N-[4-[4-(3,3,3-trifluoropropyl)piperazin-1-yl]-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine
C126H131F3N40O7S8 — CID 163505270
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[[(3R)-3-methoxypyrrolidin-1-yl]methyl]-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(5-methyl-1H-pyrazol-4-yl)-N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-(1H-pyrazol-4-yl)-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(1H-pyrazol-4-yl)-N-[4-[4-(3,3,3-trifluoropropyl)piperazin-1-yl]-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine
N-[4-[[(3R)-3-methoxypyrrolidin-1-yl]methyl]-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(5-methyl-1H-pyrazol-4-yl)-N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-(1H-pyrazol-4-yl)-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(1H-pyrazol-4-yl)-N-[4-[4-(3,3,3-trifluoropropyl)piperazin-1-yl]-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine (PubChem CID 163505270) has the molecular formula C126H131F3N40O7S8 and a molecular weight of 2631.24 g/mol. Its IUPAC name is N-[4-[[(3R)-3-methoxypyrrolidin-1-yl]methyl]-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(5-methyl-1H-pyrazol-4-yl)-N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-(1H-pyrazol-4-yl)-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(1H-pyrazol-4-yl)-N-[4-[4-(3,3,3-trifluoropropyl)piperazin-1-yl]-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine.
Molecular Properties
| Compound Name | N-[4-[[(3R)-3-methoxypyrrolidin-1-yl]methyl]-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(5-methyl-1H-pyrazol-4-yl)-N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-(1H-pyrazol-4-yl)-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(1H-pyrazol-4-yl)-N-[4-[4-(3,3,3-trifluoropropyl)piperazin-1-yl]-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine |
|---|---|
| PubChem CID | 163505270 |
| Molecular Formula | C126H131F3N40O7S8 |
| Molecular Weight | 2631.24 g/mol |
| Exact Mass | 2628.88 |
| IUPAC Name | N-[4-[[(3R)-3-methoxypyrrolidin-1-yl]methyl]-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(5-methyl-1H-pyrazol-4-yl)-N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(propan-2-yloxymethyl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-(1H-pyrazol-4-yl)-[1,3]thiazolo[5,4-b]pyridin-2-amine;N-[4-(4-propan-2-ylsulfonylpiperazin-1-yl)-2-pyridinyl]-5-pyridin-4-yl-[1,3]thiazolo[5,4-b]pyridin-2-amine;5-(1H-pyrazol-4-yl)-N-[4-[4-(3,3,3-trifluoropropyl)piperazin-1-yl]-2-pyridinyl]-[1,3]thiazolo[5,4-b]pyridin-2-amine |
| SMILES | CC(C)OCc1ccnc(Nc2nc3ccc(-c4ccncc4)nc3s2)c1.CC(C)S(=O)(=O)N1CCN(c2ccnc(Nc3nc4ccc(-c5ccncc5)nc4s3)c2)CC1.CC(C)S(=O)(=O)N1CCN(c2ccnc(Nc3nc4ccc(-c5cn[nH]c5)nc4s3)c2)CC1.CO[C@@H]1CCN(Cc2ccnc(Nc3nc4ccc(-c5ccncc5)nc4s3)c2)C1.Cc1[nH]ncc1-c1ccc2nc(Nc3cc(COC(C)C)ccn3)sc2n1.FC(F)(F)CCN1CCN(c2ccnc(Nc3nc4ccc(-c5cn[nH]c5)nc4s3)c2)CC1 |
| InChI | InChI=1S/C23H25N7O2S2.C22H22N6OS.C21H21F3N8S.C21H24N8O2S2.C20H19N5OS.C19H20N6OS/c1-16(2)34(31,32)30-13-11-29(12-14-30)18-7-10-25-21(15-18)28-23-27-20-4-3-19(26-22(20)33-23)17-5-8-24-9-6-17;1-29-17-7-11-28(14-17)13-15-4-10-24-20(12-15)27-22-26-19-3-2-18(25-21(19)30-22)16-5-8-23-9-6-16;22-21(23,24)4-6-31-7-9-32(10-8-31)15-3-5-25-18(11-15)30-20-29-17-2-1-16(28-19(17)33-20)14-12-26-27-13-14;1-14(2)33(30,31)29-9-7-28(8-10-29)16-5-6-22-19(11-16)27-21-26-18-4-3-17(25-20(18)32-21)15-12-23-24-13-15;1-13(2)26-12-14-5-10-22-18(11-14)25-20-24-17-4-3-16(23-19(17)27-20)15-6-8-21-9-7-15;1-11(2)26-10-13-6-7-20-17(8-13)24-19-23-16-5-4-15(22-18(16)27-19)14-9-21-25-12(14)3/h3-10,15-16H,11-14H2,1-2H3,(H,25,27,28);2-6,8-10,12,17H,7,11,13-14H2,1H3,(H,24,26,27);1-3,5,11-13H,4,6-10H2,(H,26,27)(H,25,29,30);3-6,11-14H,7-10H2,1-2H3,(H,23,24)(H,22,26,27);3-11,13H,12H2,1-2H3,(H,22,24,25);4-9,11H,10H2,1-3H3,(H,21,25)(H,20,23,24)/t;17-;;;;/m.1..../s1 |
| InChIKey | CYBKWWSYFLVUAZ-IQTGGXRUSA-N |
| XLogP | 24.51 |
| TPSA | 547.56 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 48 |
| Rotatable Bonds | 36 |
| Heavy Atoms | 184 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2631.24 |
| LogP ≤ 5 | 24.51 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 48 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163505270 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.